Post-approval studies (Phase 4)Ended earlyNCT05038878
What this trial is testing
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
Who this might be right for
Mild Autonomous Cortisol Excess
Icahn School of Medicine at Mount Sinai 4